Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Antitubercular Agents therapeutic use"" wg kryterium: Temat


Tytuł :
Isoniazid resistant tuberculosis- a cause for concern?
Autorzy :
Stagg, H R
Lipman, M C
McHugh, T D
Jenkins, H E
Pokaż więcej
Temat :
Global Health
Phenotype
Mycobacterium tuberculosis/drug effects
Isoniazid/therapeutic use
bacterial infections and mycoses
National Health Programs
Treatment Outcome
Tuberculosis, Multidrug-Resistant/diagnosis
Article
Genotype
Antitubercular Agents/therapeutic use
Tuberculosis/diagnosis
Humans
Źródło :
Stagg, H R, Lipman, M C, McHugh, T D & Jenkins, H E 2017, ' Isoniazid-resistant tuberculosis: a cause for concern? ', The international journal of tuberculosis and lung disease, vol. 21, no. 2, pp. 129-139 . https://doi.org/10.5588/ijtld.16.0716
Opis pliku :
application/pdf
Tytuł :
Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study
Autorzy :
Bothamley, Graham H
Lange, Christoph
TBnet study
Pokaż więcej
Temat :
ddc:616
Antitubercular Agents/therapeutic use
Decontamination/methods
Developing Countries
Drug Resistance
Bacterial/genetics
Europe
Extensively Drug-Resistant Tuberculosis/diagnosis/drug therapy
Humans
Infection Control/methods
Microbial Sensitivity Tests
Mycobacterium tuberculosis/genetics
Patient Isolation/methods
Rifampin/therapeutic use
Surveys and Questionnaires
Tuberculosis
Multidrug-Resistant/diagnosis/drug therapy
Ultraviolet Rays
Drug-resistance
PCR
Infection control
Źródło :
Respiratory Medicine, Vol. 132 (2017) pp. 68-75
Tytuł :
MDR-TB Outbreak among HIV-Negative Tunisian Patients followed during 11 Years
Autorzy :
Naira Dekhil
Nedra Meftahi
Besma Mhenni
Saloua Ben Fraj
Raja Haltiti
Sameh Belhaj
Helmi Mardassi
Pokaż więcej
Temat :
Cancer Treatment
MESH: Tuberculosis, Multidrug-Resistant/microbiology
Pharmaceutics
MESH: Male
Bacteria
Infectious Diseases
MESH: Mycobacterium tuberculosis/genetics
MESH: Tuberculosis, Multidrug-Resistant/drug therapy
Mycobacterium Tuberculosis
Restriction Fragment Length Polymorphism Analysis
Chemotherapy
Oncology
Antimicrobial Resistance
Molecular Biology Techniques
Gene Mapping
Pharmacology
MESH: Female
MESH: Adult
Actinobacteria
Biology and Life Sciences
Tuberculosis
Bacterial Diseases
MESH: Antitubercular Agents/therapeutic use
MESH: Disease Outbreaks
Science
Multi-Drug-Resistant Tuberculosis
Restriction Fragment Mapping
Organisms
Molecular Biology
Microbial Control
Research Article
MESH: HIV Seronegativity
MESH: Tuberculosis, Multidrug-Resistant/epidemiology
MESH: Antitubercular Agents/pharmacology
Clinical Medicine
MESH: Young Adult
Clinical Oncology
Drug Therapy
Research and Analysis Methods
Microbiology
MESH: Humans
Medicine
Tropical Diseases
[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology
MESH: Mycobacterium tuberculosis/drug effects
Medicine and Health Sciences
MESH: Tunisia/epidemiology
MESH: Microbial Sensitivity Tests
Źródło :
PLoS ONE, Public Library of Science, 2016, 11 (4), pp.e0153983. ⟨10.1371/journal.pone.0153983⟩
PLoS ONE, Vol 11, Iss 4, p e0153983 (2016)
Tytuł :
Management of latent Mycobacterium tuberculosis infection:WHO guidelines for low tuberculosis burden countries
Autorzy :
Getahun, Haileyesus
Matteelli, Alberto
Abubakar, Ibrahim
Aziz, Mohamed Abdel
Baddeley, Annabel
Barreira, Draurio
Den Boon, Saskia
Borroto Gutierrez, Susana Marta
Bruchfeld, Judith
Burhan, Erlina
Cavalcante, Solange
Cedillos, Rolando
Chaisson, Richard
Chee, Cynthia Bin-Eng
Chesire, Lucy
Corbett, Elizabeth
Dara, Masoud
Denholm, Justin
de Vries, Gerard
Falzon, Dennis
Ford, Nathan
Gale-Rowe, Margaret
Gilpin, Chris
Girardi, Enrico
Go, Un-Yeong
Govindasamy, Darshini
Grant, Alison D
Grzemska, Malgorzata
Harris, Ross
Horsburgh, C Robert
Ismayilov, Asker
Jaramillo, Ernesto
Kik, Sandra
Kranzer, Katharina
Lienhardt, Christian
LoBue, Philip
Lönnroth, Knut
Marks, Guy
Menzies, Dick
Migliori, Giovanni Battista
Mosca, Davide
Mukadi, Ya Diul
Mwinga, Alwyn
Nelson, Lisa
Nishikiori, Nobuyuki
Oordt-Speets, Anouk
Rangaka, Molebogeng Xheedha
Reis, Andreas
Rotz, Lisa
Sandgren, Andreas
Sañé Schepisi, Monica
Schünemann, Holger J
Sharma, Surender Kumar
Sotgiu, Giovanni
Stagg, Helen R
Sterling, Timothy R
Tayeb, Tamara
Uplekar, Mukund
van der Werf, Marieke J
Vandevelde, Wim
van Kessel, Femke
van't Hoog, Anna
Varma, Jay K
Vezhnina, Natalia
Voniatis, Constantia
Vonk Noordegraaf-Schouten, Marije
Weil, Diana
Weyer, Karin
Wilkinson, Robert John
Yoshiyama, Takashi
Zellweger, Jean Pierre
Raviglione, Mario
Pokaż więcej
Temat :
Antirheumatic Agents/therapeutic use
Antitubercular Agents/therapeutic use
Coinfection/epidemiology
Comorbidity
Disease Management
Drug Users
Emigrants and Immigrants
Evidence-Based Medicine
HIV Infections/epidemiology
Health Personnel
Homeless Persons
Humans
Interferon-gamma Release Tests
Isoniazid/therapeutic use
Kidney Failure, Chronic/epidemiology
Latent Tuberculosis/diagnosis
Mass Screening
Practice Guidelines as Topic
Prisoners
Public Health
Radiography, Thoracic
Renal Dialysis
Rifampin/analogs & derivatives
Risk Assessment
Silicosis/epidemiology
Substance-Related Disorders/epidemiology
Transplant Recipients
Tuberculin Test
Tumor Necrosis Factor-alpha/antagonists & inhibitors
World Health Organization
Źródło :
Getahun, H, Matteelli, A, Abubakar, I, Aziz, M A, Baddeley, A, Barreira, D, Den Boon, S, Borroto Gutierrez, S M, Bruchfeld, J, Burhan, E, Cavalcante, S, Cedillos, R, Chaisson, R, Chee, C B-E, Chesire, L, Corbett, E, Dara, M, Denholm, J, de Vries, G, Falzon, D, Ford, N, Gale-Rowe, M, Gilpin, C, Girardi, E, Go, U-Y, Govindasamy, D, Grant, A D, Grzemska, M, Harris, R, Horsburgh, C R, Ismayilov, A, Jaramillo, E, Kik, S, Kranzer, K, Lienhardt, C, LoBue, P, Lönnroth, K, Marks, G, Menzies, D, Migliori, G B, Mosca, D, Mukadi, Y D, Mwinga, A, Nelson, L, Nishikiori, N, Oordt-Speets, A, Rangaka, M X, Reis, A, Rotz, L, Sandgren, A, Sañé Schepisi, M, Schünemann, H J, Sharma, S K, Sotgiu, G, Stagg, H R, Sterling, T R, Tayeb, T, Uplekar, M, van der Werf, M J, Vandevelde, W, van Kessel, F, van't Hoog, A, Varma, J K, Vezhnina, N, Voniatis, C, Vonk Noordegraaf-Schouten, M, Weil, D, Weyer, K, Wilkinson, R J, Yoshiyama, T, Zellweger, J P & Raviglione, M 2015, ' Management of latent Mycobacterium tuberculosis infection : WHO guidelines for low tuberculosis burden countries ', European Respiratory Journal, vol. 46, no. 6, pp. 1563-1576 . https://doi.org/10.1183/13993003.01245-2015
Opis pliku :
application/pdf
Tytuł :
Avaliação da taxa de acesso à prescrição médica do tratamento preventivo de tuberculose com isoniazida em serviço especializado de HIV/aids
Evaluation of the rate of access to prescription of preventive treatment of tuberculosis with isoniazid in a specialized HIV/AIDS outpatient clinic
Autorzy :
Camila de Melo Picone
Pokaż więcej
Temat :
Antituberculosos/uso terapêutico
HIV/epidemiologia
Isoniazida
Síndrome da imunodeficiência adquirida
Teste tuberculínico/utilização
Tuberculose latente/enfermagem
Tuberculose latente/quimioterapia
Acquired Immunodeficiency Syndrome
Antitubercular agents /therapeutic use
HIV/epidemiology
Isoniazid
Latent tuberculosis/drug therapy
Latent tuberculosis/nursing
Tuberculin test/utilization
Źródło :
Biblioteca Digital de Teses e Dissertações da USP
Universidade de São Paulo

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies